Navigation Links
Researchers identify new way to control stone fruit disease
Date:2/18/2014

Researchers at the University of Kent and East Malling Research have identified a new way of controlling a fungal disease that can have a devastating impact on the UK's valuable cherry and plum crops.

Brown rot disease caused by the agent Monilinia laxa attacks stone fruit as well as causing blossom wilt and twig canker. Traditionally, this has been controlled through the use of fungicide treatments, but in some cases these are now becoming ineffective.

Now researchers from the two organisations have identified a new strategy for controlling the disease, using biological control agents derived from isolates from UK cherries and plums.

The researchers identified 12 possible isolates and then narrowed this down to two via a series of tests on detached fruit. Controlled sets of cherries and plums with and without the biological control agents added - were placed in conditions known to induce the onset of brown rot disease.

Professor Peter Jeffries, of the University's School of Biosciences, said: 'Brown rot disease is a major problem for the UK's cherry and plum producers and in a growing number of cases traditional fungicide treatments are becoming ineffective.

'Our research found that microbial antagonists against the brown rot disease can be found from indigenous sources in the UK and that they are capable of preventing the disease in controlled conditions.

'The challenge now will be to see whether these biocontrol agents can be adapted commercially and be used by the stone fruit industry to control brown rot disease.'

Currently, East Malling Research is exploiting ways with commercial companies to formulate the two strains of biocontrol agents and conduct pilot commercial trialling of formulated products.


'/>"/>

Contact: Martin Herrema
M.J.Herrema@kent.ac.uk
01-227-823-581
University of Kent
Source:Eurekalert

Page: 1

Related biology news :

1. Study by UC Santa Barbara researchers suggests that bacteria communicate by touch
2. UC Santa Barbara researchers discover genetic link between visual pathways of hydras and humans
3. Researchers attempt to solve problems of antibiotic resistance and bee deaths in one
4. UNH researchers find African farmers need better climate change data to improve farming practices
5. Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock
6. Researchers uncover molecular pathway through which common yeast becomes fungal pathogen
7. Researchers print live cells with a standard inkjet printer
8. Columbia Engineering and Penn researchers increase speed of single-molecule measurements
9. Researchers reveal how a single gene mutation leads to uncontrolled obesity
10. Researchers discover novel therapy for Crohns disease
11. New paper by Notre Dame researchers describes method for cleaning up nuclear waste
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology: